Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Jiulan Technology is a specialized biotechnology and computational chemistry company based in Hangzhou, China, focusing on AI-driven drug discovery and molecular simulation. The company provides advanced software solutions and research services designed to accelerate the early-stage drug development process for pharmaceutical and academic partners. By integrating high-performance computing with biological data, Jiulan Technology aims to optimize lead compound identification and molecular docking. Their core business revolves around the development of proprietary algorithms for predicting protein-ligand interactions and chemical properties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Jiulan Technology.